Leclanché S.A. (SIX Swiss Exchange: LECN), a Swiss company specialized in the production of large-format lithium-ion cells, announced the nomination of Christoph Cleve, for election to its Board of Directors at its Annual General Meeting on April 16, 2012. In addition, the company communicated that Dr Jürgen Diegruber has decided not to stand for re-election.
Rolf Eckrodt, Chairman of the Board of Directors, commented: „Through his successful career in leading investment banks, Christoph Cleve has gained in-depth business development, management and financial experience. I am very pleased that Christoph Cleve has agreed to stand for election to our Board, allowing him to share his extensive know-how with the company.“
Mr Eckrodt added: "We would like to thank Dr Jürgen Diegruber for his valuable support during the expansion phase of the company. We wish him great success in his other projects, which need his full presence, and in all future endeavors."
Biography of Christoph Cleve
Christoph Cleve, German citizen, was born in 1956. Mr. Cleve began his professional career with Deutsche Bank AG in 1983, where he worked 17 years in different management positions including head syndicated loans and global head leveraged finance. From 2000 until 2004 he was managing director and head leveraged finance Europe at JP Morgan Chase and member of the German management of JP Morgan Chase. In October 2004, Mr. Cleve joined Barclays Capital where he held several management positions including co-head investment banking Europe. Since 2009 Mr. Cleve is self-employed and makes investments in small and medium sized enterprises in which he also takes a seat in the board of directors and advises companies in financing and capital markets matters. Mr. Cleve holds a law degree from the University of Strasbourg.
